Details of the Metabolic Reaction (MR)

General Information of This Metabolic Reaction (MR) (ID: MR006700)
Formula
SVG example
Reactant Dronabinol Product 8alpha-OH-delta-9-Tetrahydrocannabinol
Reactant Info Product Info
Metabolic Enzyme Cytochrome P450 3A4 (CYP3A4) DME Info
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR006686 Dronabinol 11-Hydroxy-delta-9-THC Oxidation - 11-hydroxylation Dronabinol [1], [2], [3], [4]
MR006696 Dronabinol 11-OH-delata-Tetrahydrocannabinol Oxidation - Aliphatic hydroxylation Dronabinol [1], [5]
MR013922 Dronabinol 7-alpha-Hydroxy-delta-9-THC Oxidation - 7-hydroxylation Dronabinol [1]
MR006693 Dronabinol 7-beta-Hydroxy-delta-9-THC Oxidation - 7-hydroxylation Dronabinol [1]
MR006697 Dronabinol 7-OH-delta-9-Tetrahydrocannabinol Oxidation - Aliphatic hydroxylation Dronabinol [1], [5]
MR006698 Dronabinol 7alpha-OH-delta-9-Tetrahydrocannabinol Oxidation - Aliphatic hydroxylation Dronabinol [1], [5]
MR006694 Dronabinol 8-beta-Hydroxy-delta-9-THC Oxidation - 8-hydroxylation Dronabinol [1]
MR006691 Dronabinol 8-Hydroxy-delta-9-THC Oxidation - 8-hydroxylation Dronabinol [1]
MR006699 Dronabinol 8-OH-delta-9-Tetrahydrocannabinol Unclear Dronabinol [1], [5]
MR006695 Dronabinol 9-alpha,10-alpha-epoxyhexahydrocannabinol Oxidation - 9, 10-epoxidation Dronabinol [1], [4]
References
1 Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675.
2 CYP2C-catalyzed delta9-tetrahydrocannabinol metabolism: kinetics, pharmacogenetics and interaction with phenytoin. Biochem Pharmacol. 2005 Oct 1;70(7):1096-103.
3 Characterization of human hepatic and extrahepatic UDP-glucuronosyltransferase enzymes involved in the metabolism of classic cannabinoids
4 Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions
5 Cytochromes P450: a structure-based summary of biotransformations using representative substrates Drug Metab Rev. 2008;40(1):1-100. doi: 10.1080/03602530802309742.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.